What is the ticker symbol for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals trades under the ticker EIGR on NASDAQ.

What sector does Eiger BioPharmaceuticals operate in?

Eiger BioPharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze EIGR in a portfolio?

PortView shows EIGR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Eiger BioPharmaceuticals (EIGR) Stock Analysis

NASDAQHealthcareBiotechnology

$1.73+0.00%

1-year price historyRange $1.30 – $37.80

52-week range$1.73

$1.73$1.90

What Eiger BioPharmaceuticals does

Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.

Key metrics

Market cap

$2.55M

P/E (TTM)

-0.03

EPS (TTM)

$-58.50

Beta

1.84

Dividend yield

0.00%

Revenue / share

$10.68

50-day avg

$1.73

200-day avg

$1.73

52-week high

$1.90

52-week low

$1.73

CEO

David Apelian

ETFs linked to EIGR

Broad-market and Healthcare sector ETFs an investor holding Eiger BioPharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how EIGR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EIGR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Eiger BioPharmaceuticals?: Eiger BioPharmaceuticals trades under the ticker EIGR on NASDAQ.
Which exchange is EIGR listed on?: EIGR is listed on NASDAQ.
What sector does Eiger BioPharmaceuticals operate in?: Eiger BioPharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EIGR in a portfolio?: PortView shows EIGR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.